Sunshine Biopharma Inc. Effect on Future Cash Flows, Amount
Sunshine Biopharma Inc. (SBFM) reported Effect on Future Cash Flows, Amount of $1.50 billion for the 0-month period ending 2024-02-10, per its 10-K filed 2025-04-01.
Financial Statements › Notes
us-gaap:EffectOnFutureCashFlowsAmount · last filed 2025-04-01
- 2024-02-10: Effect on Future Cash Flows, Amount 0 month $1.50B.
| Period end | Effect on Future Cash Flows, Amount 0 month |
|---|---|
| 2024-02-10 | $1.50B 10-K · filed 2025-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |